The effect of tumor-targeted photodynamic therapy (PDT) was improved by designing nanotheranostics to promote oxygenation in a tumor microenvironment (TME) wherein hypoxia, acidosis, and the elevated levels of H 2 O 2 are three main characteristics. In this study, a carbon dot (CD) PDT agent recently developed by our group was firstly applied as reducing agent to react with potassium permanganate for fabricating CDs/manganese dioxide (CDs/MnO 2 ) composites, which were in turn modified with polyethylene glycol (PEG) to form water-soluble CDs/MnO 2 -PEG nanohybrids. In a normal physiological environment, the as-prepared nanohybrids exhibited quenched fluorescence, weak singlet oxygen generation, and low magnetic resonance imaging (MRI) signal. However, given the high sensitivity of MnO 2 to the TME, the CDs/MnO 2 -PEG nanohybrids changed from an "off" to an "on" state with synchronously enhanced fluorescence, singlet oxygen generation, and MRI signal in the TME. In vitro and in vivo analyses have revealed that CDs/MnO 2 -PEG nanohybrids could be applied as TME-driven, turn-on nanotheranostics for the MR/fluorescence bimodal imaging-guided PDT of cancer. Moreover, complete clearance of CDs/MnO 2 -PEG nanohybrids from the body of mice was observed, indicating their low long-term toxicity and good biocompatibility. This work offers a new nanotheranostic candidate for modulating the unfavorable TME, particularly for the targeted PDT of cancer through precise positioning and oxygen generation.
INTRODUCTION
Nanotheranostics that combine medical diagnostics and therapeutics into one nanosystem have been considered as the key toward realizing personalized nanomedicine for the precise treatment of cancer in the future [1] [2] [3] [4] [5] [6] [7] . In the past decade, numerous studies have explored various multifunctional theranostics nanosystems based on external (e.g., ultrasound, light, magnetic and electrical fields) or internal factors (e.g., pH value, redox, environment, and enzyme) [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . Among them, pH/H 2 O 2 -driven nanotheranostics have been proven capable of markedly improving the O 2 -dependent photodynamic therapy (PDT) of hypoxic tumors, as revealed by the interesting results obtained in pre-clinical animal experiments. The reason is that pH/H 2 O 2 -driven nanotheranostics can produce great amounts of oxygen in situ and modify the pH via a redox reaction with the acidic H 2 O 2 in the tumor microenvironment (TME) [22] [23] [24] [25] [26] . For example, the extensively investigated pH/H 2 O 2 -driven nanotheranostics are MnO 2 nanoparticles and MnO 2 -containing nanocomposites, which can improve tumor oxygenation to enhance the efficiency of PDT in the TME [27] . In addition, these nanoparticles and nanocomposites can also be rapidly reduced to water-soluble Mn 2+ for T1-weighted magnetic resonance imaging (MRI) [28] . Thus, the study of MnO 2 -based nanotheranostics can offer insight into the development of next-generation intelligent stimuli-responsive nanomedicines for the efficient diagnosis and treatment of cancer in the future. However, MnO 2 -based nanotheranostics fabricated by current synthetic methods are hindered by the following limitations: 1) the complex and tedious preparation procedure; and 2) the need for drugs or photosensitizers for loading on MnO 2 nanoparticles [29] . Therefore, a simple method must be established for the preparation of MnO 2 -based nanotheranostics.
Carbon dots (CDs), a new type of biocompatible fluorescent carbon material, have gained considerable interest in recent years because of their advantageous properties, including tunable emission, non-blinking fluorescence (FL) property, high photostability, excellent water solubility, and favorable biocompatibility [30] [31] [32] . These characteristics make CDs suitable for various applications, such as imaging agents [33, 34] , biosensors [35, 36] , and metal-free catalysts [37] [38] [39] . Meanwhile, nanotheranostics based on CDs have been recently developed because of the easy modification of CDs with drugs [40] [41] [42] [43] [44] [45] [46] [47] [48] . Moreover, the light-induced singlet oxygen ( 1 O 2 ) or heat generation of CDs have been developed recently by our group for PDT or photothermal therapy (PTT) of cancer, indicating their intrinsic capability for nanotheranostics [49] [50] [51] . According to the previous report [52] , CDs also can function as reducing agents; therefore, the development of CDs with intrinsic photodynamic or photothermal properties as the reducing agent for preparing pH/H 2 O 2 -driven, CDs-based nanohybrids may provide new nanotheranostics candidates for simultaneous imaging and therapy of cancer.
Our group recently developed a novel CD PDT agent with a high 1 O 2 quantum yield exceeding 1.3, thus enabling it to act as a novel nanotheranostics for the FL imaging-guided PDT of cancer [49] . In this study, such a CD PDT agent was firstly utilized as the reducing agent to react with KMnO 4 . The resulting products were then modified with PEG to form CDs/MnO 2 -PEG nanohybrids. In a normal physiological environment (pH 7.4), the obtained CDs/MnO 2 -PEG nanohybrids exhibited quenched fluorescence, weak 1 O 2 generation, and low MRI signal. With the introduction of acidic H 2 O 2 into the TME of solid tumors (pH 6.5-6.9), the quenched fluorescence of CDs was recovered/enhanced for diagnosis/ monitoring by the decomposition of MnO 2 . The simultaneously generated Mn 2+ can then be utilized as a contrast agent for MRI. Moreover, the MnO 2 -H 2 O 2 redox reaction at a reduced pH generated massive O 2 in situ, thereby significantly promoting the PDT efficacy of CDs (Scheme 1). Furthermore, complete clearance of CDs/ MnO 2 -PEG from the body of mice was achieved, indicating the low long-term toxicity and good biocompatibility of the fabricated nanohybrids. These findings highlight the promising potential of CDs/MnO 2 -PEG nanohybrids for modulating the unfavorable TME and enhancing the PDT response to cancer.
EXPERIMENTAL SECTION

Chemicals and materials
Potassium permanganate (KMnO 4 ) and hydrogen peroxide (H 2 O 2 , 30 wt.% solution) were purchased from J&K Chemical Co. Amino group terminated glycol (mPEG-NH 2 , M w =2,000) was acquired from YareBio. All analytical-grade chemicals were commercially available and used without further purification unless indicated otherwise.
Synthesis of CDs/MnO 2
The strongly oxidizing KMnO 4 was one-step reduced by CDs to MnO 2 . Then, the positively charged CDs were loaded on the formed MnO 2 nanosheets to obtain CDs/ MnO 2 complexes. In brief, we prepared CDs by subjecting polythiophene (PT2) to hydrothermal treatment following our procedure in our previous study [49] . Then, 50 mL of KMnO 4 solution (0.02 mg mL −1 ) was dropwise added to the activated CDs and stirred at room temperature for 6 h. Untreated KMnO 4 and unbound CDs were removed by ultrafiltration at 18,000 rpm for 10 min and washed with water thrice. After ultrasonic dispersion was conducted for 5 min, the large particles of the CDs/ MnO 2 complexes were removed by centrifugation (7,000 rpm) and filtering through 0.22 mm membranes. The loading of the CDs onto the MnO 2 nanosheets was verified by measuring the samples with a UV-vis spectrophotometer. The quenching effect of MnO 2 on the CDs was observed with a luminescence spectrometer.
Synthesis of CDs/MnO 2 -PEG
To prepare CDs/MnO 2 -PEG NPs, approximately 25 mL of mPEG-NH 2 aqueous solution (25 mg, 1 mg mL −1 ) was added to the solution under ultrasonication and then stirred vigorously at room temperature for 12 h to guarantee an efficient PEGylation. The resulting CDs/MnO 2 -PEG was purified by a three-day dialysis procedure using a dialysis bag (MWCO 5,000 Da) to remove the unreacted mPEG-NH 2 .
CDs loading ratio
The UV-vis-NIR spectra of CDs in CDs/MnO 2 nanohybrids were obtained after the nanohybrids were dissolved at pH 6.5 for 6 h. The UV-vis peaks at 492 nm were used to determine the concentration of CDs in the CDs/MnO 2 samples after the absorbance contributed by MnO 2 nanoparticles was removed by dissolving the samples at pH 6.5. The loading efficiency (Ø CDs ) of CDs can be calculated by the equation: Ø CDs =(Abs CDs /Abs CDs/MnO 2 -PEG )× 100%, where Abs CDs is the absorbance of CDs, and Abs CDs/MnO 2 -PEG is the absorbance of CDs/MnO 2 -PEG with the same concentration.
Detection of singlet oxygen
The CDs/MnO 2 -PEG samples were loaded in a quartz   ARTICLES . . . . . . . . . . . . . . . . . . . . . . . . . SCIENCE CHINA Materials   1326 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ), and the other group was added with a PBS solution with a normal physiological pH. The cells were then incubated with 2,7-dichlorodi-hydrofluoresce in diacetate (DCFH-DA, 1 mg mL −1 , 2 μL) for 10 min prior to observation. Cells incubated only with DCFH-DA served as the control group.
For the cell cytotoxicity assay, the cells were seeded into a 96-well plate with a density of 5×10 4 cells per well until the cells adhered and were then incubated with increasing concentrations (12.5, 25, 50, 100, 150, and 200 μg mL −1 ) of CDs/MnO 2 -PEG with or without acidic H 2 O 2 . After being incubated for 24 h in the dark, the standard thiazolyl tetrazolium (MTT) test was conducted to evaluate the cell viabilities relative to the untreated cells.
For PDT, HeLa cells seeded in 96-well plates were incubated with various concentrations of CDs/MnO 2 -PEG for 4 h. The 96-well plates were placed in a glove box that had been ventilated under N 2 atmosphere in advance. This setup was maintained for 30 min before being exposed to 635 nm irradiation at a power density of 100 mW cm −2 for 30 min under circulating N 2 . Then, the ) at pH 6.5, and the other group was added with PBS with a normal physiological pH. Afterward, both groups were exposed to 635 nm irradiation at a power density of 100 mW cm ) laser served as the control group. Images were captured with a Nikon C1silaser scanning confocal microscope. The major organs and tissues (i.e., liver, spleen, kidney, heart, lung and the tumor) were weighed, digested, and solubilized in chloroazotic acid under heating for 2 h. After the organic compounds were completely oxidized, each sample was diluted to 10 mL with deionized water. The relative contents of Mn in the different samples were measured thrice by inductively coupled plasma mass spectrometry (ICP-MS).
Animal modal
In vivo O 2 generation was detected by using a photoacoustic (PA) tomography system with an excitation wavelength of 680 nm to measure the oxygenated hemoglobin (HBO 2 ) content at different time points (0, 4, 8, 12, and 24 h) after the i.v. administration of CDs/MnO 2 -PEG (1 mg mL −1 , 200 μL). Oxygenation inside the tumor was reflected by the changes in HBO 2 content.
For in vivo PDT, the tumor-bearing nude mice were randomly divided into four groups (each group consisting of five mice): (1) without any treatment; (2) 635 nm laser irradiation (100 mW cm 
Histopathological examination
The tissues (i.e., heart, liver, spleen, kidney and lung) at 30 d p.i. of CDs/MnO 2 -PEG and the tumors of the four groups at 1 d post-treatment were harvested and fixed in 4% formalin solution. Histopathological examinations were performed in accordance with standard laboratory procedures. The tissue or tumor samples were numbered and given blindly to a pathologist for conventional processing and analysis. All samples were embedded in paraffin blocks, sectioned into 4 μm slices, and mounted onto glass slides. The sections were stained with hematoxylin and eosin (H&E) prior to observation, and images were captured by an optical microscope.
RESULTS AND DISCUSSION
Characterization of CDs/MnO 2 -PEG After the CDs and KMnO 4 underwent a redox reaction, X-ray photoelectron spectroscopy (XPS) was performed to assess the compositions of the resulting samples. The survey spectrum in Fig. S1 indicated the presence of C, Mn and O. As shown in Fig. 1a , the deconvolution of the high-resolution XPS spectra of Mn 2p revealed two peaks at 642.2 and 653.9 eV, which corresponded to the Mn (IV) 2p 2/3 and Mn(IV) 2p 1/2 spin-orbit peaks, respectively, of Mn 4+ with a spin-energy separation of 11.7 eV [53] . This phenomenon confirmed that the positively charged CDs reduced KMnO 4 into MnO 2 . To improve their stability, the obtained CDs/MnO 2 composites were modified with aminoterminated PEG (M w ≈ 2,000) through Mn-N coordinate bonding (Fig. S2) [54] . As revealed by transmission electron microscopy (TEM) in Fig. 1b , the CDs/ MnO 2 -PEG nanohybrids displayed an approximate average size of 180 nm. The high-resolution TEM image of the CDs loaded onto MnO 2 ( Fig. S3a) revealed that the inter planar distance was approximately 0.31 nm, indicating that the reacted CDs retained their original crystallinity. Energy-dispersive X-ray spectroscopy spectrum also proved that the elements (i.e., Mn, C, O, etc.) were present in the CDs/MnO 2 -PEG nanohybrids (Fig.  S3b) . As shown in Fig. 1c , the zeta potential changed from +37.1 mV for CDs to −21.7 mV for CDs/MnO 2 because of the formation of hydrogen bonds in the aqueous solution and the transformation of the surface charge by the MnO 2 nanoparticles. After being stirred with aminoterminated PEG, the zeta potential of the CDs/MnO 2 -PEG nanohybrids increased to −17.9 mV, indicating the successful formation of CDs/MnO 2 -PEG nanohybrids, which were favorable for long blood circulation.
UV-vis spectra (Fig. 1d) revealed that the four characteristic peaks of KMnO 4 (between 500 and 550 nm) disappeared after the reaction in the presence of the positively charged CD PDT agent. However, a new broad absorbance band appeared in the range of 300-800 nm, implying the surface plasmon band of generated MnO 2 . As shown in Fig. 1e , the fluorescence of the CDs at the maximum emissive peak of 690 nm was significantly absorbed by the MnO 2 because of the significant overlap between the emission spectrum of CDs and the absorption spectrum of MnO 2 . This phenomenon suggested the CDs/MnO 2 -PEG nanohybrids displayed faint fluorescence signal under normal physiological conditions. The loading efficiency of CDs onto CDs/MnO 2 -PEG was evaluated by obtaining the UV-vis spectra of the CDs at 492 nm. The maximum loading efficiency reached up to approximately 65% (Fig. S4) . In addition, the obtained CDs/MnO 2 -PEG was highly dispersible and stable in water, PBS, FBS, and DMEM. No obvious aggregation was observed even after a prolonged time of 7d (Fig. 1f) SCIENCE CHINA Materials. . . . . . . . . . . . . . . . . . . . . . . . . . . . As shown by the comparison of the absorption and fluorescence spectra of CDs/MnO 2 -PEG at pH 7.4 and 6.5 in Fig. 2a and b , the initial absorption spectrum of the CDs appeared, and the markedly enhanced FL intensity of the CDs was also observed. Then, dissolved O 2 in the reacted solution was quantitatively tested by an oxygen probe (ST300D, portable Dissolved Oxygen Meters, Chang zhou OHAUS Instrument Factory) with increasing concentrations of CDs/MnO 2 -PEG nanohybrids (MnO 2 : 0, 50, 100 mmol L −1 ) which resulted in the rapid generation of oxygen in acidic H 2 O 2 (10 mmol L −1 ) as shown in Fig. 2c , and gas bubbles were clearly observed at 100 mmol L −1 of H 2 O 2 (Fig. S5 ). These findings indicated that the CDs/MnO 2 -PEG can be used for the quantitative detection of acidic H 2 O 2 by examining the FL intensity of CDs and the production of oxygen. As shown in Fig. S6 , the size of CDs/MnO 2 -PEG nanohybrids also changed from~180 nm (at pH 7.4) to 5-20 nm (at pH 6.5), indicating the decomposition of MnO 2 nanoparticles in the acidic condition.
The capability of the CDs/MnO 2 -PEG nanohybrids to produce 1 CDs/MnO 2 -PEG nanohybrids was due to the enhanced O 2 generation resulting from the MnO 2 -catalyzed decomposition of H 2 O 2 under hypoxia. The T1-weighted MRI of the CDs/MnO 2 -PEG nanohybrids were further examined under neutral (pH 7.4) and acidic conditions (pH 6.5). As shown in Fig. 2e and f, the as-prepared CDs/MnO 2 -PEG nanohybrids displayed concentration-dependent T1-weighted MRI signals under both neutral and acidic conditions. However, the CDs/ MnO 2 -PEG nanohybrids under acidic conditions (pH 6.5) exhibited a more strongly enhanced T1-weighted MRI than those under neutral conditions (pH 7.4) because of the reduction of MnO 2 into Mn 2+ by the acidic H 2 O 2 [59] . The r1 value of the CDs/MnO 2 -PEG nanohybrids drastically increased from 0.4763 (mmol L 
In vitro imaging and PDT
In vitro experiments were conducted to determine whether the as-prepared CDs/MnO 2 -PEG nanohybrids can serve as an effective, pH/H 2 O 2 -driven, turn-on nanotheranostics for the multimodal imaging-guided PDT of cancer. Confocal images (Fig. 3a) showed that HeLa cells treated with CDs/MnO 2 -PEG nanohybrids under neutral conditions (pH 7.4) exhibited weak fluorescence because of the quenching effect of MnO 2 nanoparticles on CDs. However, the fluorescent signals of CDs were significantly increased after acidic H 2 O 2 was added because of the MnO 2 nanoparticles were disintegrated [60] , thereby releasing of the red emissive CDs. Z-Stack imaging further demonstrated that the CDs/MnO 2 -PEG nanohybrids were localized in the cytoplasm rather than the cell membrane (Fig. S8) . These results proved that the asprepared CDs/MnO 2 -PEG nanohybrids can be applied as . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fig. 3b , the cells incubated with CDs/MnO 2 -PEG nanohybrids under neutral condition (pH 7.4) displayed week fluorescence under N 2 , implying that scarce 1 O 2 production occurred. However, under acidic conditions, the green fluorescence was further enhanced by continuous incubation for 10 min, indicating that was effectively generated.
An in vitro viability assay was performed on HeLa cells under N 2 atmosphere to investigate the PDT effect of CDs/MnO 2 -PEG nanohybrids. As shown in Fig. 3c , the CDs/MnO 2 -PEG nanohybrids exhibited negligible adverse effects on the viabilities of the HeLa cells at the tested concentrations ranging from 6.25 to 200 µg mL −1 with or without acidic H 2 O 2 , thus indicating the favorable biocompatibility of the CDs/MnO 2 -PEG nanohybrids. However, in the presence of acidic H 2 O 2 (pH 6.5), a significant concentration-dependent cytotoxicity of the CDs/MnO 2 -PEG nanohybrids was observed, and a 95% inhibitory effect was achieved at 200 µg mL −1 of CDs/ MnO 2 -PEG nanohybrids upon 635 nm laser irradiation. By contrast, the cell viability slightly decreased at pH 7.4. The in vitro PDT effect of the CDs/MnO 2 -PEG nanohybrids under a TME with acidic H 2 O 2 conditions (pH 6.5) under N 2 atmosphere was verified by conducting a calcein AM and PI co-staining assay. The observed green fluorescence indicated that few cell deaths occurred at pH 7.4 even after the irradiation time was prolonged to 10 min (Fig. 3d) . However, at pH 6.5, a homogeneous red fluorescence was observed at 200 μg mL −1 of the CDs/ MnO 2 -PEG nanohybrids upon 635 nm laser irradiation, indicating complete cell death. These in vitro results suggested that CDs/MnO 2 -PEG can act as an effective pH/H 2 O 2 -driven, turn-on nanotheranostics for the imaging-guided PDT of cancer under an acidic and hypoxia TME.
In vivo MR/FL imaging and real-time biodistribution
To investigate the feasibility of CDs/MnO 2 -PEG nanohybrids for in vivo MRI, mice bearing subcutaneous 4T1 tumors of approximately 100 mm 3 were selected as models. In vivo MRI was performed at different times (0, 4, 12, and 24 h) with the use of a 7T MR scanner. As shown in Fig. 4a and b , a weak MR signal was observed in the tumor site at 4 h p.i. of CDs/MnO 2 -PEG nanohybrids. This finding indicated that the CDs/MnO 2 -PEG nanohybrids accumulated in the tumor area because of the enhanced permeability and retention (EPR) effect and the gradual reduction of MnO 2 into Mn 2+ in the mildly acidic TME [61, 62] . The MR signal intensity at the tumor site reached a fastigium at 12 h p.i. and decreased at 24 h p.i. The T1 signals observed in the kidneys reached their maximum at 12 h p.i. (Fig. 4c-e) , suggesting the renal clearance of the Mn 2+ decomposed from MnO 2 . By contrast, no obvious T1 signal changes were observed in the liver because of its neutral environment.
Subsequently, the FL imaging of a tumor-bearing mouse was conducted in vivo at different time intervals after the i.v. injection of CDs/MnO 2 -PEG nanohybrids (1 mg mL −1 , 200 μL). Fig. 4f and g show that the FL intensity at the tumor site rapidly increased within 12 h p.i., and then plateaued. Ex vivo imaging of major organs and tumors collected from mice at 12 h p.i. was further examined. As shown in Fig. 4h , the excised tumor tissue displayed strong FL intensity, whereas the liver and the kidney presented very low signals. These findings agreed well with the in vivo MRI behavior. Therefore, both MR and FL imaging indicated that 12 h p.i. was the optimal time for the subsequent PDT. And the CDs/MnO 2 -PEG nanohybrids were responsive only in the TME but maintained an "off" state in normal physiological environments, suggesting that CDs/MnO 2 -PEG nanohybrids can be used as a tumor-targeted, multifunctional theranostic for eliminating the damage toward normal tissues during PDT.
The real-time biodistribution of CDs/MnO 2 -PEG nanohybrids at different times was examined by ICP-MS, which is a sensitive method that can accurately detect the content of Mn in different organs. For ex vivo analyses, tumor-bearing mice were i.v. injected with CDs/MnO 2 -PEG nanohybrids (1 mg mL Fig. 4i illustrates the trends of biodistribution and metabolic clearance of the Mn ions in the tumors. Analysis of the statistical results revealed that CDs/MnO 2 -PEG nanohybrids accumulated in the tumor through the EPR effect. This accumulation increased within 1-12 h p.i., plateaued at 12 h p.i., and then steadily decreased over time. In addition, CDs/MnO 2 -PEG nanohybrids also accumulated in the liver, the lungs, the kidneys, the spleen, and the heart; the accumulation likewise steadily decreased over time, resulting in the complete removal of the CDs/MnO 2 -PEG nanohybrids from the main organs and tumors after 4 weeks.
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In vivo O 2 -enhanced PDT
To further demonstrate the ability of CDs/MnO 2 -PEG nanohybrids to ameliorate tumor hypoxia, PA imaging was performed to detect HBO 2 content in the tumors at different time points after the i.v. injection of the CDs/ MnO 2 -PEG nanohybrids. As shown in Fig. 5a and b, the mean intensities of the HBO 2 signs increased with time and reached a maximum value at approximately 12 h p.i., indicating the successful alleviation of tumor hypoxia due to the MnO 2 -triggered decomposition of H 2 O 2 into O 2 . Such enhanced oxygenation in the TME was favorable for increasing the efficiency of in vivo PDT. Then, the in vivo PDT efficacy of the CDs/MnO 2 -PEG nanohybrids was evaluated. Balb/c mice bearing subcutaneous 4T1 tumors were divided into four groups: Group 1: without any treatment; Group 2: laser irradiation only; Group 3: CDs/ MnO 2 -PEG nanohybrids (1 mg mL Fig. 5c , the mice in Group 4 exhibited a significant suppression of tumor growth, demonstrating a remarkably improved therapeutic efficacy. By contrast, all tumor tissues of the mice in Groups 1, 2, and 3 continued to grow (Fig. 5e) . The in vivo toxicity of the CDs/MnO 2 -PEG nanohybrids was also investigated by monitoring the weight change of the mice during the study period. As shown in Fig. 5d , no abnormal changes were observed in any of the groups, indicating the absence of acute toxicity of the CDs/MnO 2 -PEG nanohybrids in vivo.
The microscopy images of the H&E-stained tumor slices further revealed that the PDT triggered by CDs/ MnO 2 -PEG nanohybrids severely damaged the tumor cells, whereas the tumor cells in the control groups mostly retained their regular morphology (Fig. 5f ). The H&E-stained slices of the main organs (heart, liver, spleen, lung and kidney) were also evaluated for histology analysis at 30 d post i.v. injection of CDs/MnO 2 -PEG nanohybrids. Compared with the cells of a healthy mouse, those in the examined tissues retained their normal morphology (Fig.  S9) , showing neither significant inflammation nor damage. Overall, these results illustrate that CDs/MnO 2 -PEG nanohybrids are a highly effective, scarcely biotoxic PDT agent in vivo.
CONCLUSIONS
In summary, pH/H 2 O 2 -responsive CDs/MnO 2 -PEG nanohybrids were successfully synthesized via the redox reaction between the CD PDT agent and KMnO 4 followed by PEGylation. The as-prepared CDs/MnO 2 -PEG nanohybrids possessed the following characteristics: (1) quenched fluorescence, weak singlet oxygen generation, and low MRI signal in the normal physiological environment; (2) synchronously enhanced fluorescence, singlet oxygen generation, and MRI signal in the tumor microenvironment; and (3) low toxicity and complete clearance from the body. In vitro and in vivo analyses reveal that the low-toxic CDs/MnO 2 -PEG nanohybrids can be applied as pH/H 2 O 2 -driven, turn-on nanotheranostics for the concurrent bimodal MR/FL imaging and oxygen-elevated PDT of solid tumors if the TME is regulated. This work offers a new nanotheranostic candidate for modulating the unfavorable TME, particularly for the targeted PDT of cancer through precise positioning and oxygen generation. 
